Professor Bodo Lippitz: Neurosurgery

Professor Bodo Lippitz



  • Not Fee assured

About me

In the 25 years of my clinical work in neurosurgery I have focused early on minimal invasive techniques in the treatment of brain tumours. Stereotactic and microsurgical training in Homburg and Aachen, Germany, Assistant Professor at the Duke University, Durham, USA . Further specialisation at the Department of Neurosurgery of the Karolinska University, Stockholm, where the concept of radiosurgery and the Gamma Knife technology had been developed. Between 2000 and 2001 and 2006-2008 Director of the Karolinska Gamma Knife Center. Between 1999 and 2005 Director of the International Gamma Knife Training Courses at the Karolinska University Stockholm, which were mandatory for all new Gamma Knife Centers worldwide. Since 10/2006 Professor of Neurosurgery (University Aachen, Germany). Since 11/07 President of the European Gamma Knife Society (EGKS). Since 9/2008 Co-Director of the Bupa Cromwell Hospital Gamma Knife Centre. My clinical priority is the Gamma Knife treatment of benign and malignant brain tumours.

Areas of interest

Brain metastases, meningioma, acoustic neurinoma and vascular radiosurgery. AVM, pituitary adenoma, gamma knife radiosurgery. Neuro-oncology.

Medical secretaries

About me
My qualifications & training
Consultant's practices
Information for healthcare professionals

Information for healthcare professionals (Bupa patients only, last 12 months)

Procedures completed

  • A0380

    Stereotactic radiotherapy (SRT) using GammaKnife or similar SRT technology - (1-5)

    Bupa Cromwell Hospital (1-5)

Edit details Print page

The information contained on Finder is submitted by consultants, therapists and facilities, and is declared by these third parties to be correct and compliant with the standards and codes of conduct specified by their relevant regulatory body. Bupa cannot guarantee the accuracy of all of the information provided.

You can find out more about the data and information on Finder and our website terms of use here.